ATNF
Price:
$1.95
Market Cap:
$1.89M
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, Cali...[Read more]
Industry
Biotechnology
IPO Date
2017-06-27
Stock Exchange
NASDAQ
Ticker
ATNF
According to 180 Life Sciences Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.17. This represents a change of -102.40% compared to the average of 7.07 of the last 4 quarters.
The mean historical PE Ratio of 180 Life Sciences Corp. over the last ten years is 11.01. The current -0.17 PE Ratio has changed -254.42% with respect to the historical average. Over the past ten years (40 quarters), ATNF's PE Ratio was at its highest in in the June 2017 quarter at 626.93. The PE Ratio was at its lowest in in the June 2019 quarter at -241.04.
Average
11.01
Median
-0.67
Minimum
-5.98
Maximum
89.04
Discovering the peaks and valleys of 180 Life Sciences Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 503.72%
Maximum Annual PE Ratio = 89.04
Minimum Annual Increase = -101.15%
Minimum Annual PE Ratio = -5.98
Year | PE Ratio | Change |
---|---|---|
2023 | -0.08 | -53.59% |
2022 | -0.17 | -97.22% |
2021 | -5.98 | 47.24% |
2020 | -4.06 | 503.72% |
2019 | -0.67 | -34.21% |
2018 | -1.02 | -101.15% |
The current PE Ratio of 180 Life Sciences Corp. (ATNF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.07
5-year avg
-2.19
10-year avg
11.01
180 Life Sciences Corp.’s PE Ratio is greater than Zura Bio Limited (-9.00), less than Phio Pharmaceuticals Corp. (-0.15), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.55), greater than Cardio Diagnostics Holdings, Inc. (-0.75), less than Altamira Therapeutics Ltd. (-0.03), greater than Immix Biopharma, Inc. (-2.98), greater than Enveric Biosciences, Inc. (-0.36), greater than Palisade Bio, Inc. (-0.31), less than CNS Pharmaceuticals, Inc. (-0.00), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Navidea Biopharmaceuticals, Inc. (0.03), less than ZyVersa Therapeutics, Inc. (-0.10), greater than Apexigen, Inc. (-0.36),
Company | PE Ratio | Market cap |
---|---|---|
-9.00 | $230.86M | |
-0.15 | $2.25M | |
-0.55 | $4.53M | |
-0.75 | $6.94M | |
-0.03 | $2.04M | |
-2.98 | $54.08M | |
-0.36 | $4.53M | |
-0.31 | $4.25M | |
-0.00 | $4.60M | |
-0.00 | $188.18K | |
0.03 | $100.08K | |
-0.10 | $2.70M | |
-0.36 | $9.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 180 Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 180 Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is 180 Life Sciences Corp.'s PE Ratio?
How is the PE Ratio calculated for 180 Life Sciences Corp. (ATNF)?
What is the highest PE Ratio for 180 Life Sciences Corp. (ATNF)?
What is the 3-year average PE Ratio for 180 Life Sciences Corp. (ATNF)?
What is the 5-year average PE Ratio for 180 Life Sciences Corp. (ATNF)?
How does the current PE Ratio for 180 Life Sciences Corp. (ATNF) compare to its historical average?